Lewis & Clark Pharmaceuticals' Seed VC - II Round

Lewis & Clark Pharmaceuticals raised a round of funding on April 17, 2013. Investors include CIT GAP Funds.

Lewis & Clark Pharmaceuticals is a biotechnology company developing novel proprietary compounds from a technology platform based on adenosine chemistry and biology.…

Articles about Lewis & Clark Pharmaceuticals' Seed VC - II Round: